Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Democratising the treatment of depression through novel, cost-effective fDCS techniques

Reference number
Coordinator Flow Neuroscience AB
Funding from Vinnova SEK 500 000
Project duration July 2017 - January 2018
Status Completed

Important results from the project

This project was conducted to perform a feasibility study into the commercial and technical viability of a depression treatment based on transcranial direct current stimulation (tDCS) and digital therapy, at home. The goal was to analyse the market opportunity and the patients´ response to the product from a usability perspective.

Expected long term effects

- The product was found to be commercially viable with demonstrated demand from a large and reachable target market of end-users who are willing to pay for its services. - Usability trials showed a positive response from potential users and valuable feedback was collected.

Approach and implementation

- The demand for the product was measured using sales tests online. Traffic was directed toward landing pages and different metrics were collected. - Usability trials where users were exposed to the product was also conducted and feedback was collected.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 14 June 2019

Reference number 2017-03350

Page statistics